These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8432142)

  • 1. The acute effect of ipratropium bromide bronchodilator therapy on cough clearance in COPD.
    Bennett WD; Chapman WF; Mascarella JM
    Chest; 1993 Feb; 103(2):488-95. PubMed ID: 8432142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional mucus transport following unproductive cough and forced expiration technique in patients with airways obstruction.
    Hasani A; Pavia D; Agnew JE; Clarke SW
    Chest; 1994 May; 105(5):1420-5. PubMed ID: 8181329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD.
    Martin RJ; Bartelson BL; Smith P; Hudgel DW; Lewis D; Pohl G; Koker P; Souhrada JF
    Chest; 1999 May; 115(5):1338-45. PubMed ID: 10334150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
    Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease.
    Bleecker ER; Britt EJ
    Am J Med; 1991 Oct; 91(4A):24S-27S. PubMed ID: 1835291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.
    Pavia D; Bateman JR; Sheahan NF; Clarke SW
    Eur J Respir Dis; 1980 Oct; 61(5):245-53. PubMed ID: 6451446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enhanced supramaximal flows on cough clearance.
    Bennett WD; Zeman KL
    J Appl Physiol (1985); 1994 Oct; 77(4):1577-83. PubMed ID: 7836171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ineffectiveness of cough for enhancing mucus clearance in asymptomatic smokers.
    Bennett WD; Chapman WF; Gerrity TR
    Chest; 1992 Aug; 102(2):412-6. PubMed ID: 1643924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD.
    LeDoux EJ; Morris JF; Temple WP; Duncan C
    Chest; 1989 May; 95(5):1013-6. PubMed ID: 2523291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
    Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
    Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipratropium bromide (Atrovent) as inhalation powder. A double-blind study of comparison with ipratropium as a pressure aerosol in patients with reversible airways obstruction.
    Maesen FP; Smeets JJ; Bernsen R; Cornelissen PJ
    Allergy; 1986 Jan; 41(1):37-42. PubMed ID: 2938515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance.
    Taylor RG; Pavia D; Agnew JE; Lopez-Vidriero MT; Newman SP; Lennard-Jones T; Clarke SW
    Thorax; 1986 Apr; 41(4):295-300. PubMed ID: 2943050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
    Dai L; Li X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.
    Chest; 1994 May; 105(5):1411-9. PubMed ID: 8181328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.